CAR T cell therapy for myasthenia gravis

[ad_1]

Myasthenia gravis is a chronic and often disabling autoimmune disease characterized by muscle weakness. A key underlying mechanism is the production of autoantibodies by plasma cells – but current therapies do not adequately control these processes. As …

Sources

1/ https://Google.com/

2/ https://www.nature.com/articles/d41591-023-00062-2

The mention sources can contact us to remove/changing this article

[ad_2]

Leave a Reply

Your email address will not be published. Required fields are marked *

Related Posts